查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390600

2023-2028年按产品类型、给药途径、疾病、应用和地区分類的疫苗佐剂市场报告

Vaccine Adjuvants Market Report by Product Type, Route of Administration, Diseases, Application, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球疫苗佐剂市场规模达到8.84亿美元。展望未来， IMARC Group预计到2028年市场规模将达到18.12亿美元，2022-2028年复合年增长率（CAGR）为12.71%。人们日益关注开发有效的疫苗、大众传染病的流行以及人们对疫苗接种在预防疾病和改善公共卫生方面重要性的认识不断提高，是推动市场的一些主要因素。

疫苗佐剂是一种添加到疫苗中以增强疫苗引发的免疫反应的物质或化合物。它们经过广泛的测试和监管监督，以确保它们不会在註射部位造成除了轻微和短暂反应之外的极端影响。它们与疫苗中的抗原相容，不应干扰其活性。它们可作为免疫增强剂，确保更强大和持久的免疫反应。它们显着提高身体识别和记忆抗原的能力，从而产生更强大和持久的免疫反应。

目前，对疫苗佐剂的需求不断增加，因为它们允许使用较小的疫苗剂量，这在疫苗生产推动市场成长的情况下至关重要。除此之外，疫苗佐剂的日益普及，因为它们能够在大流行期间快速开发疫苗，并允许在不影响功效的情况下使用更少量的抗原，这也促进了市场的成长。此外，各国政府机构也越来越多地进行疫苗接种活动以消除各种疾病，这提供了良好的市场前景。除此之外，生物技术、免疫学和基因组学的不断进步正在支持市场的成长。此外，人们越来越认识到疫苗接种在预防疾病和改善公共卫生方面的重要性，这也促进了市场的成长。

疫苗佐剂市场趋势/驱动因素：

越来越重视开发有效的疫苗

目前对开发有效疫苗的日益关注正在对疫苗佐剂市场的成长产生积极影响。除此之外，疫苗佐剂在改善疫苗产生的免疫反应方面发挥着至关重要的作用，从而确保更好地预防传染病。随着製药公司和研究机构不断投资开发新出现疾病的新型疫苗，对先进高效佐剂的需求不断增加。此外，正在进行的全球疫苗接种运动旨在消除由各种病毒引起的多种传染病，这凸显了疫苗佐剂在加速生产安全有效疫苗方面的重要性。旨在创造具有更高免疫原性的疫苗的持续研发（R＆D）活动正在将佐剂的需求推向新的高度。

佐剂技术不断进步

目前，佐剂技术的不断进步正在推动疫苗佐剂市场的成长。随着持续的研究和开发 (R&D) 措施不断增强疫苗配方中使用的佐剂的能力和功效，该行业正在经历显着的转变。研究人员和科学家目前正在开发和微调创新佐剂技术，这些技术能够显着增强疫苗引起的免疫反应。这些进步正在应用于针对各种传染病的疫苗配方中。此外，佐剂技术的进步正在促进更高的疫苗开发效率和有效性。这意味着对新出现的感染威胁（例如新型病原体和不断进化的病毒株）做出更快速的反应。

群众传染病流行率上升

目前，传染病在大众中日益流行，对疫苗佐剂市场的成长产生了积极影响。这种现象主要归因于人们对疫苗接种作为预防各种传染病的重要性的认识的提高。由于这些疾病持续对公共卫生构成重大威胁，对有效疫苗的需求不断增长。此外，加快开发疫苗的迫切性导致佐剂研发（R＆D）投资的增加。对疫苗佐剂的高度关注有利于当前市场，并为未来的成长机会铺平道路。

疫苗佐剂行业区隔：

IMARC Group提供了全球疫苗佐剂市场报告各细分市场主要趋势的分析，以及 2023-2028 年全球、区域和国家层面的预测。我们的报告根据产品类型、给药途径、疾病和应用对市场进行了分类。

按产品类型划分：

佐剂乳剂

病原体成分

颗粒佐剂

组合佐剂

其他的

助剂乳液主导市场

该报告根据产品类型对市场进行了详细的细分和分析。这包括佐剂乳液、病原体成分、颗粒佐剂、组合佐剂等。根据该报告，佐剂乳液代表了最大的部分。

佐剂乳液是用于各个领域（包括疫苗）的专门製剂，用于增强免疫系统。它们可以帮助稳定抗原，否则这些抗原可能会降解或被迅速从体内清除。佐剂乳剂可以使疫苗抗原更具免疫原性，这意味着它们能够更好地刺激免疫反应。当处理本身免疫原性较低的抗原时，这一点尤其重要。此外，疫苗中使用的佐剂乳液在获得监管部门批准之前要经过严格的安全性和有效性测试。此外，使用佐剂乳剂可以产生更有效的疫苗，提供更好的目标疾病的保护。这在需要强烈且持续的免疫反应的情况下尤其重要。

依给药途径分类：

口服

肌肉注射

鼻内

皮下

皮内

其他的

肌肉注射占市场最大份额

报告还根据给药途径对市场进行了详细的细分和分析。这包括口服、肌肉内、鼻内、皮下、皮内等。报告称，肌肉注射占据了最大的市场份额。

肌肉注射疫苗具有许多好处，有助于其在免疫计划中的广泛使用。由于肌肉中的血液供应增强，它促进了快速而强大的免疫反应，确保疫苗抗原有效吸收到血液中。它还保持疫苗的稳定性和完整性，保护脆弱的抗原并实现可靠的疫苗传递。此外，它用途广泛，适用于多种疫苗，包括灭活疫苗、减毒活疫苗和基于蛋白质的製剂，使其成为各种免疫接种的首选途径。这种适应性延伸到从婴儿到老年人的所有年龄段，促进了全面的疫苗接种计划。

依疾病分类：

癌症

传染性疾病

其他的

传染病占市场最大份额

报告还根据疾病对市场进行了详细的细分和分析。这包括癌症、传染病等。报告称，传染病占据最大的市场份额。

疫苗佐剂在开发有效的传染病疫苗中发挥着至关重要的作用。它们刺激并增强对疫苗中抗原的免疫反应。这意味着可以使用较少的抗原，从而降低疫苗生产成本和潜在的副作用。疫苗佐剂可以帮助延长免疫反应，确保人体在较长时间内持续产生抗体和记忆细胞。这可以带来针对传染源的更持久的保护。此外，可以客製化疫苗佐剂以引发特定类型的免疫反应。此外，它们可以透过增强老年人的免疫反应来帮助克服免疫老化。

按应用划分：

研究

商业的

研究在市场上占有最大份额

报告还提供了基于应用程式的详细市场细分和分析。这包括研究和商业。报告显示，研究占据了最大的市场份额。

疫苗佐剂是疫苗研究领域的关键组成部分，在提高疫苗的有效性和安全性方面发挥关键作用。这些物质被添加到疫苗配方中以增强免疫反应，最终更好地预防传染病。佐剂在开发使用传统疫苗方法难以标靶的病原体的疫苗时特别有价值，例如具有快速突变表面蛋白或弱免疫原性成分的病毒。它们是疫苗研究中不可或缺的工具，可增强免疫反应、减少抗原剂量并微调免疫系统反应的特定性。此外，科学家正在研究新型佐剂配方和递送方法，以最大限度地提高其有效性，同时最大限度地减少潜在的副作用。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美表现出明显的主导地位，占据最大的疫苗佐剂市场份额

市场研究报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美占据最大的市场份额。

由于医疗保健行业不断进步，为患者提供品质治疗，北美占据了最大的市场份额。除此之外，对用于治疗罕见疾病的各种新型疫苗、疗法和药物的开发的日益关注正在推动市场的成长。除此之外，生物技术和免疫学领域的不断进步，使得能够开发出安全性更高、功效更强的佐剂，正在支持市场的成长。

由于新型病毒引起的多种传染病的盛行率不断上升，预计亚太地区在这一领域的规模将进一步扩大。此外，越来越多地进行公众意识活动和教育工作来宣传疫苗接种的好处，这也促进了市场的成长。

竞争格局：

主要市场参与者正在透过探索新的佐剂配方、递送机制以及与疫苗的组合来开发创新且更有效的佐剂，以提高其功效和安全性。他们还与疫苗製造商、生物技术公司和研究机构建立策略伙伴关係和合作，以共享专业知识和资源并进入新市场。顶尖公司正在透过开发可用于各种类型疫苗（包括传染病、癌症和自体免疫疾病疫苗）的佐剂来扩大其产品组合。他们也致力于确保其佐剂符合必要的监管要求和安全标准。领先公司正在扩大在新兴市场的业务，这些市场对疫苗和疫苗佐剂的需求不断增长。他们还建立製造设施、分销网络以及与当地组织的合作伙伴关係。

该报告对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

辅助科技公司

佐瓦蒂斯

阿吉努斯公司

布伦塔格SE

凯姆贸易物流公司

中超有限公司

禾大国际股份有限公司

英维健

诺瓦瓦克斯公司

奥兹生物科学公司

维罗美泰克公司

最近的发展：

2022 年 1 月，Adjuvance Tecchnologies Inc. 宣布美国专利商标局 (USPTO) 授予一项涉及半合成皂苷佐剂的美国专利，该佐剂表现出改进的佐剂活性和降低的毒性。

2021 年 9 月，Agenus Inc. 宣布成立子公司 SaponiQx，该子公司将推动新型佐剂发现和疫苗生产的创新。

2023 年 6 月，Novavax Inc. 宣布批准国家药品监管局 (ANRP) 批准 R21/Matrix-M (TM) 疟疾疫苗，其中含有其基于皂苷的佐剂 Matrix-M。布吉纳法索用于儿童。

本报告回答的关键问题

  • 2022年全球疫苗佐剂市场规模是多少
  • 2023-2028年全球疫苗佐剂市场预计成长率是多少
  • 推动全球疫苗佐剂市场的关键因素是什么
  • COVID-19对全球疫苗佐剂市场有何影响
  • 根据产品类型，全球疫苗佐剂市场的细分如何
  • 根据给药途径，全球疫苗佐剂市场的细分如何
  • 基于疾病的全球疫苗佐剂市场的细分是什么
  • 基于应用的全球疫苗佐剂市场区隔如何
  • 全球疫苗佐剂市场的重点区域有哪些
  • 10. 全球疫苗佐剂市场的主要参与者/公司有哪些？

本报告回答的关键问题

  • 2022年全球疫苗佐剂市场规模有多大？
  • 2023-2028年全球疫苗佐剂市场的预期成长率是多少？
  • 推动全球疫苗佐剂市场的关键因素是什么？
  • COVID-19对全球疫苗佐剂市场有何影响？
  • 根据产品类型，全球疫苗佐剂市场的细分如何？
  • 根据给药途径，全球疫苗佐剂市场的细分如何？
  • 全球疫苗佐剂市场根据疾病的划分是怎样的？
  • 根据应用，全球疫苗佐剂市场的细分如何？
  • 全球疫苗佐剂市场的重点区域有哪些？
  • 全球疫苗佐剂市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球疫苗佐剂市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依产品类型分類的市场区隔

  • 佐剂乳剂
    • 市场走向
    • 市场预测
  • 病原体成分
    • 市场走向
    • 市场预测
  • 颗粒佐剂
    • 市场走向
    • 市场预测
  • 组合佐剂
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：按管理途径分類的市场

  • 口服
    • 市场走向
    • 市场预测
  • 肌肉注射
    • 市场走向
    • 市场预测
  • 鼻内
    • 市场走向
    • 市场预测
  • 皮下
    • 市场走向
    • 市场预测
  • 皮内
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：疾病导致的市场分裂

  • 癌症
    • 市场走向
    • 市场预测
  • 传染性疾病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按应用分類的市场区隔

  • 研究
    • 市场走向
    • 市场预测
  • 商业的
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Adjuvance Tecchnologies Inc.
    • Adjuvatis
    • Agenus Inc.
    • Brenntag SE
    • Chemtrade Logistics Inc.
    • CSL Limited
    • Croda International Plc
    • Invivogen
    • Novavax Inc.
    • OZ Biosciences
    • Virometix AG
Product Code: SR112023A4385

Abstract

The global vaccine adjuvants market size reached US$ 884 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,812 Million by 2028, exhibiting a growth rate (CAGR) of 12.71% during 2022-2028. The growing focus on developing effective vaccines, increasing prevalence of infectious diseases among the masses, and rising awareness about the importance of vaccination in preventing diseases and improving public health are some of the major factors propelling the market.

Vaccine adjuvants are substances or compounds added to vaccines to enhance the immune response triggered by the vaccine. They undergo extensive testing and regulatory oversight to ensure that they do not cause extreme effects beyond mild and transient reactions at the injection site. They are compatible with the antigens in the vaccine and should not interfere with their activity. They serve as immunological boosters, ensuring a more robust and long-lasting immune response. They significantly improve the ability of the body to recognize and remember antigens, resulting in a more robust and durable immune response.

At present, the increasing demand for vaccine adjuvants as they allow for the use of smaller vaccine doses, which can be critical in situations where vaccine production is impelling the growth of the market. Besides this, the rising popularity of vaccine adjuvants, as they enable the rapid development of vaccines during pandemics and allow smaller quantities of antigens to be used without compromising efficacy, is contributing to the growth of the market. In addition, the growing conduction of vaccination drives by governing agencies of various countries to eradicate various diseases is offering a favorable market outlook. Apart from this, increasing advancements in biotechnology, immunology, and genomics are supporting the growth of the market. Additionally, the rising awareness about the importance of vaccination in preventing diseases and improving public health is bolstering the growth of the market.

Vaccine Adjuvants Market Trends/Drivers:

Growing focus on developing effective vaccines

The growing focus on developing effective vaccines is currently exerting a positive influence on the growth of the vaccine adjuvants market. Besides this, vaccine adjuvants play a crucial role in improving the immune response generated by vaccines, thereby ensuring better protection against infectious diseases. As pharmaceutical companies and research institutions continue to invest in the development of novel vaccines for emerging diseases, the need for advanced and efficient adjuvants is rising. Furthermore, the ongoing global vaccination campaigns for eradicating numerous infectious diseases caused by various viruses are underscoring the significance of vaccine adjuvants in expediting the production of safe and effective vaccines. The continuous research and development (R&D) activities aimed at creating vaccines with higher immunogenicity are propelling the demand for adjuvants to new heights.

Rising advancements in adjuvant technology

At present, rising advancements in adjuvant technology are bolstering the growth of the vaccine adjuvants market. This sector is experiencing a remarkable transformation as ongoing research and development (R&D) initiatives are continually enhancing the capabilities and efficacy of adjuvants used in vaccine formulations. Researchers and scientists are currently developing and fine-tuning innovative adjuvant technologies that are capable of significantly augmenting the immune response elicited by vaccines. These advancements are being implemented in vaccine formulations that target various infectious diseases. Furthermore, the advancements in adjuvant technology are fostering greater vaccine development efficiency and effectiveness. This translates into a more rapid response to emerging infectious threats, such as novel pathogens and evolving viral strains.

Increasing prevalence of infectious diseases among the masses

The increasing prevalence of infectious ailments among the masses is currently positively influencing the growth of the vaccine adjuvants market. This phenomenon is primarily attributed to the heightened awareness of the importance of vaccination as a preventive measure against various infectious diseases. As these diseases continue to pose a significant public health threat, there is a growing demand for effective vaccines. Additionally, the urgency to develop vaccines at an accelerated pace is leading to an increase in investments in adjuvant research and development (R&D). This heightened focus on vaccine adjuvants is benefiting the current market and paving the way for future growth opportunities.

Vaccine Adjuvants Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global vaccine adjuvants market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product type, route of administration, diseases and application.

Breakup by Product Type:

Adjuvant Emulsions

Pathogen Components

Particulate Adjuvants

Combination Adjuvants

Others

Adjuvant emulsions dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes adjuvant emulsions, pathogen components, particulate adjuvants, combination adjuvants, and others. According to the report, adjuvant emulsions represented the largest segment.

Adjuvant emulsions are specialized formulations used in various fields, including vaccines, to enhance the immune system. They can help stabilize antigens that may otherwise degrade or be rapidly cleared from the body. Adjuvant emulsions can make vaccine antigens more immunogenic, meaning they are better at stimulating an immune response. This is particularly important when dealing with antigens that are less immunogenic on their own. Moreover, adjuvant emulsions used in vaccines go through rigorous testing for safety and efficacy before receiving regulatory approval. Furthermore, the use of adjuvant emulsions can result in a more effective vaccine, providing better protection against the targeted disease. This is particularly important in cases where a strong and sustained immune response is needed.

Breakup by Route of Administration:

Oral

Intramuscular

Intranasal

Subcutaneous

Intradermal

Others

Intramuscular holds the largest share in the market

A detailed breakup and analysis of the market based on the route of administration has also been provided in the report. This includes oral, intramuscular, intranasal, subcutaneous, intradermal, and others. According to the report, intramuscular accounted for the largest market share.

Intramuscular vaccine administration offers numerous benefits that contribute to its widespread use in immunization programs. It facilitates a rapid and robust immune response due to the enhanced blood supply in the muscles, ensuring efficient uptake of vaccine antigens into the bloodstream. It also maintains the stability and integrity of vaccines, protecting fragile antigens and enabling reliable vaccine delivery. Furthermore, it is versatile and suitable for a wide array of vaccines, including inactivated, live attenuated, and protein-based formulations, making it a preferred route for various immunizations. This adaptability extends to all age groups, from infants to the elderly, facilitating comprehensive vaccination programs.

Breakup by Diseases:

Cancer

Infectious Diseases

Others

Infectious diseases hold the biggest share in the market

A detailed breakup and analysis of the market based on the diseases has also been provided in the report. This includes cancer, infectious diseases, and others. According to the report, infectious diseases accounted for the largest market share.

Vaccine adjuvants play a crucial role in the development of effective vaccines against infectious diseases. They stimulate and enhance the immune response to the antigens present in the vaccine. This means that smaller amounts of antigen can be used, reducing the cost of vaccine production and the potential for side effects. Vaccine adjuvants can help prolong the immune response, ensuring that the body continues to produce antibodies and memory cells for an extended period. This can lead to longer-lasting protection against infectious agents. Moreover, vaccine adjuvants can be tailored to elicit specific types of immune responses. Furthermore, they can help overcome immunosenescence by boosting the immune response in older individuals.

Breakup by Application:

Research

Commercial

Research holds the maximum share in the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes research and commercial. According to the report, research accounted for the largest market share.

Vaccine adjuvants are critical components in the field of vaccine research, playing a pivotal role in enhancing the effectiveness and safety of vaccines. These substances are added to vaccine formulations to boost the immune response, ultimately leading to better protection against infectious diseases. Adjuvants are particularly valuable in the development of vaccines against pathogens that are challenging to target using traditional vaccine approaches, such as viruses with rapidly mutating surface proteins or weakly immunogenic components. They are indispensable tools in vaccine research, serving to enhance immune responses, reduce antigen doses, and fine-tune the specificity of the immune system's reaction. Furthermore, scientists are investigating novel adjuvant formulations and delivery methods to maximize their effectiveness while minimizing potential side effects.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest vaccine adjuvants market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to increasing improvements in the healthcare sector to provide quality treatment to patients. Besides this, the increasing focus on the development of various novel vaccines, therapeutics, and medications for the treatment of rare diseases is propelling the growth of the market. Apart from this, increasing improvements in the fields of biotechnology and immunology to enable the development of adjuvants with improved safety profiles and enhanced efficacy are supporting the growth of the market.

Asia Pacific is estimated to expand further in this domain due to the rising prevalence of numerous infectious diseases caused by novel viruses. Additionally, the increasing conduction of public awareness campaigns and educational efforts to promote the benefits of vaccination is bolstering the growth of the market.

Competitive Landscape:

Key market players are developing innovative and more effective adjuvants by exploring new adjuvant formulations, delivery mechanisms, and combinations with vaccines to enhance their efficacy and safety. They are also forming strategic partnerships and collaborations with vaccine manufacturers, biotech firms, and research institutions for sharing expertise and resources and accessing new markets. Top companies are expanding their product portfolios by developing adjuvants that can be used in various types of vaccines, including those for infectious diseases, cancer, and autoimmune disorders. They are also focusing on ensuring that their adjuvants meet the necessary regulatory requirements and safety standards. Leading companies are expanding their presence in emerging markets, where the demand for vaccines and vaccine adjuvants is growing. They are also establishing manufacturing facilities, distribution networks, and partnerships with local organizations.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Adjuvance Tecchnologies Inc.

Adjuvatis

Agenus Inc.

Brenntag SE

Chemtrade Logistics Inc.

CSL Limited

Croda International Plc

Invivogen

Novavax Inc.

OZ Biosciences

Virometix AG

Recent Developments:

In January 2022, Adjuvance Tecchnologies Inc. announced the issuance of a U.S. patent covering semi-synthetic saponin adjuvants that exhibits improved adjuvant activity and reduced toxicity by the United States Patent and Trademark Office (USPTO).

In September 2021, Agenus Inc. announced the launch of its subsidiary, SaponiQx, which will drive innovation in novel adjuvant discovery and vaccine production.

In June 2023, Novavax Inc. announced the approval of the R21/Matrix-M™ malaria vaccine containing its Matrix-M, a saponin-based adjuvant by Agence Nationale de la Regulation Pharmaceutique (ANRP). Burkina Faso for use in children.

Key Questions Answered in This Report

  • 1. What was the size of the global vaccine adjuvants market in 2022?
  • 2. What is the expected growth rate of the global vaccine adjuvants market during 2023-2028?
  • 3. What are the key factors driving the global vaccine adjuvants market?
  • 4. What has been the impact of COVID-19 on the global vaccine adjuvants market?
  • 5. What is the breakup of the global vaccine adjuvants market based on the product type?
  • 6. What is the breakup of the global vaccine adjuvants market based on route of administration?
  • 7. What is the breakup of the global vaccine adjuvants market based on the diseases?
  • 8. What is the breakup of the global vaccine adjuvants market based on the application?
  • 9. What are the key regions in the global vaccine adjuvants market?
  • 10. Who are the key players/companies in the global vaccine adjuvants market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vaccine Adjuvants Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Adjuvant Emulsions
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Pathogen Components
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Particulate Adjuvants
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Combination Adjuvants
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intramuscular
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Intranasal
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Subcutaneous
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Intradermal
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Diseases

  • 8.1 Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Infectious Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Research
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Commercial
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Adjuvance Tecchnologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Adjuvatis
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Agenus Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Brenntag SE
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Chemtrade Logistics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 CSL Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Croda International Plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Invivogen
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Novavax Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 OZ Biosciences
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Virometix AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Vaccine Adjuvants Market: Major Drivers and Challenges
  • Figure 2: Global: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Vaccine Adjuvants Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Vaccine Adjuvants Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Vaccine Adjuvants Market: Breakup by Diseases (in %), 2022
  • Figure 7: Global: Vaccine Adjuvants Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Vaccine Adjuvants Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Vaccine Adjuvants (Adjuvant Emulsions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Vaccine Adjuvants (Adjuvant Emulsions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Vaccine Adjuvants (Pathogen Components) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Vaccine Adjuvants (Pathogen Components) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Vaccine Adjuvants (Particulate Adjuvants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Vaccine Adjuvants (Particulate Adjuvants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Vaccine Adjuvants (Combination Adjuvants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Vaccine Adjuvants (Combination Adjuvants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Vaccine Adjuvants (Other Product Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Vaccine Adjuvants (Other Product Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Vaccine Adjuvants (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Vaccine Adjuvants (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Vaccine Adjuvants (Intramuscular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Vaccine Adjuvants (Intramuscular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Vaccine Adjuvants (Intranasal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Vaccine Adjuvants (Intranasal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Vaccine Adjuvants (Subcutaneous) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Vaccine Adjuvants (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Vaccine Adjuvants (Intradermal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Vaccine Adjuvants (Intradermal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Vaccine Adjuvants (Other Routes of Administration) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Vaccine Adjuvants (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Vaccine Adjuvants (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Vaccine Adjuvants (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Vaccine Adjuvants (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Vaccine Adjuvants (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Vaccine Adjuvants (Other Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Vaccine Adjuvants (Other Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Vaccine Adjuvants (Research) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Vaccine Adjuvants (Research) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Vaccine Adjuvants (Commercial) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Vaccine Adjuvants (Commercial) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: North America: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: North America: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United States: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United States: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Canada: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Canada: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Asia-Pacific: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Asia-Pacific: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: China: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: China: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: India: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: India: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: South Korea: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: South Korea: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Australia: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Australia: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Indonesia: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Indonesia: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Europe: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Europe: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Germany: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Germany: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: France: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: France: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: United Kingdom: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: United Kingdom: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Italy: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Italy: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Spain: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Spain: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Russia: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Russia: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Latin America: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Latin America: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Brazil: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Brazil: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Mexico: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Mexico: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Middle East and Africa: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Middle East and Africa: Vaccine Adjuvants Market: Breakup by Country (in %), 2022
  • Figure 89: Middle East and Africa: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Global: Vaccine Adjuvants Industry: SWOT Analysis
  • Figure 91: Global: Vaccine Adjuvants Industry: Value Chain Analysis
  • Figure 92: Global: Vaccine Adjuvants Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Vaccine Adjuvants Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Vaccine Adjuvants Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Vaccine Adjuvants Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Vaccine Adjuvants Market Forecast: Breakup by Diseases (in Million US$), 2023-2028
  • Table 5: Global: Vaccine Adjuvants Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Vaccine Adjuvants Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Vaccine Adjuvants Market: Competitive Structure
  • Table 8: Global: Vaccine Adjuvants Market: Key Players